Aidan is a Research Associate at Compass Carter Osborne, having joined the business in 2024. He brings experience in Board and C-suite appointments within financial services, including mandates for Retail Banks and FinTech’s, having previously worked in a Research role for a SHREK firm.
In his role, Aidan works alongside consultants, assisting in both the research process and outreach efforts to execute global C-suite mandates, with a specific focus on the private equity owned, and venture capital backed life sciences organisations.
Aidan holds a 2:1 BSc in Economics from King’s College, London, with research interest in Human Capital and International Trade.
Managing Director – International Value-Added Medicines Business (Colonis)
SVP Global Head of Quality – Listed Biologics CDMO (OXB)
VP Operations – Clinical Trial Supplies Business (Clinigen)
Medical Director – Haematology-focused Biotech (CellCentric)
Managing Director – European API CDMO (Minakem)
Chief Medical Officer – PE Backed Private Healthcare Provider (Genesis)
Looks like you’re on the US site. Choose another location to see content specific to your location
Choose your region
Choose another location to see content specific to your location